The typical case for the fund is to invest in rounds with 8 participants. Despite the Opaleye Management, startups are often financed by OrbiMed, GE Ventures, Xeraya Capital. The meaningful sponsors for the fund in investment in the same round are Xeraya Capital, Pura Vida Investments, OrbiMed. In the next rounds fund is usually obtained by Royalties Fund, OrbiMed, Deerfield Capital Management.
The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2019. Deals in the range of more than 100 millions dollars are the general things for fund.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Acutus Medical.
Related Funds
| Fund Name | Location |
| AVRO Accelerator | Australia, New South Wales, Sydney |
| Bahrain Development Bank | Bahrain, Capital Governorate, Manama |
| Chicagoland Investors | Chicago, Illinois, United States |
| Conversion Ventures LLC | New York, New York, United States |
| Essence Securities | China, Guangdong, Shenzhen |
| Frasers Property | Central, Central Region, Singapore |
| HLD | France, Ile-de-France, Paris |
| KEY Investment Partners | Colorado, Denver, United States |
| Lavni Ventures | - |
| Marc Bell Capital | Boca Raton, Florida, United States |
| Paradigm Capital Partners | Memphis, Tennessee, United States |
| Project 11 Ventures | Boston, Massachusetts, United States |
| Shanghai Ruijian Capital Management Co. | China, Shanghai |
| Shell Oil Company | Houston, Texas, United States |
| Solidus Company | Nashville, Tennessee, United States |
| TGZ Capital | New York, New York, United States |
| Ultrabuttonwood Capital | Beijing, Beijing, China |
| Xtreme Labs | California, Palo Alto, United States |
| ZIM | Canada, Ontario, Ottawa |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
IpiNovyx Bio | $10M | 05 Oct 2021 | New York, New York, United States | ||
| $80M | 20 Apr 2021 | Connecticut, United States | |||
ValenzaBio | $79M | 08 Apr 2021 | Bethesda, Maryland, United States | ||
Palvella Therapeutics | $45M | 28 May 2020 | Radnor Township, Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
IpiNovyx Bio | $10M | 05 Oct 2021 | New York, New York, United States | ||
| $80M | 20 Apr 2021 | Connecticut, United States | |||
ValenzaBio | $79M | 08 Apr 2021 | Bethesda, Maryland, United States | ||
Palvella Therapeutics | $45M | 28 May 2020 | Radnor Township, Pennsylvania, United States |
